Fig. 1
From: Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours
Kaplan-Meier analysis illustrating OS based on (a) XPA, (b) ERCC1, (c) XPF and (d) combined NER (ERCC1, XPF and XPA) expression in GCT patients (n = 207). (a) HR = 0.38, 95% CI: 0.12–1.23, p = 0.0228; (b) HR = 0.35, 95% CI: 0.03–3.56, p = 0.1295; (c) HR = 0.65, 95% CI: 0.26–1.64, p = 0.4250; and (d) HR = 0.36, 95% CI: 0.12–1.09, p = 0.0109. Blue and red lines represent low and high expression, respectively